Glutaminase

  • 阻害剤の選択性比較
  • 溶解度
カタログ番号 製品カタログ 溶解度(25°C)
DMSO アルコール
S7655 CB-839 <1 mg/mL 100 mg/mL <1 mg/mL
S7753 BPTES <1 mg/mL 100 mg/mL <1 mg/mL
S8778 UPGL00004 <1 mg/mL 25 mg/mL <1 mg/mL

Glutaminase製品

新Glutaminase製品
製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S7655

CB-839

CB-839 is a potent, selective, and orally bioavailable glutaminase inhibitor with IC50 of 24 nM for recombinant human GAC. Phase 1.

S7753

BPTES

BPTES is a potent and selective Glutaminase GLS1 (KGA) inhibitor with IC50 of 0.16 μM. It has no effect on glutamate dehydrogenase activity and causes only a very slight inhibition of γ-glutamyl transpeptidase activity.

S8778

UPGL00004

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S7655

CB-839

CB-839 is a potent, selective, and orally bioavailable glutaminase inhibitor with IC50 of 24 nM for recombinant human GAC. Phase 1.

S7753

BPTES

BPTES is a potent and selective Glutaminase GLS1 (KGA) inhibitor with IC50 of 0.16 μM. It has no effect on glutamate dehydrogenase activity and causes only a very slight inhibition of γ-glutamyl transpeptidase activity.

S8778

UPGL00004